Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

596
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
596
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

2.2K
The pathophysiology of pneumonia involves the following steps:
2.2K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

678
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
678
Pneumonia IV: Management01:28

Pneumonia IV: Management

643
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
643
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

3.2K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.2K
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

601
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
601

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quantitative chest computed tomography: regional differences in dual-energy-derived virtual vs. true non-contrast scans.

Clinical radiology·2025
Same author

Whole-genome sequencing reveals two prolonged simultaneous outbreaks involving Pseudomonas aeruginosa high-risk strains ST111 and ST235 with resistance to quaternary ammonium compounds.

The Journal of hospital infection·2024
Same author

[German S1 Guideline Long-/Post-COVID].

Pneumologie (Stuttgart, Germany)·2022
Same author

COVID-19 Lockdown Periods in 2020: Good Maintenance of Metabolic Control in Adults with Type 1 and Type 2 Diabetes.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association·2022
Same author

[Statement of the German Society for Pulmonology and Respiratory Medicine Regarding the Regulation to Use FFP and Surgical Masks in the General Population].

Pneumologie (Stuttgart, Germany)·2021
Same author

[S2k Guideline - Recommendations for Inpatient Therapy of Patients with COVID-19].

Pneumologie (Stuttgart, Germany)·2021
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
See all related articles

Related Experiment Video

Updated: Dec 13, 2025

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
08:05

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia

Published on: December 19, 2020

14.6K

[COVID-19 pneumonia].

M Pfeifer1,2,3, O W Hamer4,5

  • 1Pneumologie, Klinik und Poliklinik für Innere Medizin II, Universitätsklinikum Regensburg, Franz-Josef-Strauß-Allee 11, 93053, Regensburg, Deutschland. michael.pfeifer@ukr.de.

Der Internist
|July 31, 2020
PubMed
Summary
This summary is machine-generated.

Coronavirus disease 2019 (COVID-19) causes severe pneumonia, impacting the respiratory system. This review details COVID-19 pneumonia

Keywords:
Acute respiratory distress syndromeAntiviral agentsDexamethasoneTomography, X‑ray computedVentilation, mechanical

More Related Videos

Experimental Model to Evaluate Resolution of Pneumonia
09:49

Experimental Model to Evaluate Resolution of Pneumonia

Published on: February 17, 2023

1.7K
Methods for Detecting Cytotoxic Amyloids Following Infection of Pulmonary Endothelial Cells by Pseudomonas aeruginosa
07:27

Methods for Detecting Cytotoxic Amyloids Following Infection of Pulmonary Endothelial Cells by Pseudomonas aeruginosa

Published on: July 12, 2018

5.8K

Related Experiment Videos

Last Updated: Dec 13, 2025

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
08:05

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia

Published on: December 19, 2020

14.6K
Experimental Model to Evaluate Resolution of Pneumonia
09:49

Experimental Model to Evaluate Resolution of Pneumonia

Published on: February 17, 2023

1.7K
Methods for Detecting Cytotoxic Amyloids Following Infection of Pulmonary Endothelial Cells by Pseudomonas aeruginosa
07:27

Methods for Detecting Cytotoxic Amyloids Following Infection of Pulmonary Endothelial Cells by Pseudomonas aeruginosa

Published on: July 12, 2018

5.8K

Area of Science:

  • Pulmonary Medicine
  • Infectious Diseases
  • Radiology

Background:

  • Coronavirus disease 2019 (COVID-19) remains a significant global health concern, with respiratory system involvement being primary.
  • Severe pneumonia is a common and prognostically important manifestation of COVID-19.

Purpose of the Study:

  • To comprehensively review the pulmonary manifestations of COVID-19.
  • To discuss pathophysiology, symptomatology, and radiological features of COVID-19 pneumonia.
  • To elucidate differences from classic acute respiratory distress syndrome and their treatment implications.

Main Methods:

  • Review of current literature on COVID-19 pulmonary disease.
  • Discussion of pathophysiological mechanisms, including alveolar and vascular endothelium injury.
  • Analysis of diagnostic methods: PCR, laboratory findings, and advanced imaging.
  • Description of clinical presentation in three phases.
  • Overview of treatment strategies: supportive care, ventilation, and pharmacological interventions.

Main Results:

  • COVID-19 pneumonia involves complex acute lung injury, potentially leading to severe respiratory failure.
  • Distinct pathophysiological features differentiate it from classic acute respiratory distress syndrome.
  • Characteristic radiological findings aid in diagnosis and grading of pneumonia severity.
  • Phased symptom progression and specific laboratory markers are observed.
  • Effective treatments include supportive care, ventilation, thrombosis prevention, and targeted therapies like remdesivir and dexamethasone.

Conclusions:

  • Understanding the multifaceted nature of COVID-19 pneumonia is crucial for effective patient management.
  • Radiological and clinical features, alongside pathophysiological insights, guide diagnosis and treatment.
  • A combination of supportive, intensive care, and pharmacological interventions improves outcomes for severe COVID-19 respiratory disease.